Navigation Links
Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients
Date:4/23/2009

egimen achieved SVR. RVR is defined as undetectable virus (HCV RNA) in plasma at 4 weeks after the addition of boceprevir. In the lead-in arms, 64 percent of patients achieved RVR. Fewer patients in the lead-in arms discontinued treatment due to viral breakthrough.

"These results are very exciting and provide important insights to help further define response guided therapy using a P/R lead-in boceprevir regimen with peginterferon and ribavirin backbone treatment," said Paul Kwo, M.D., associate professor of medicine and medical director, liver transplantation, Department of Medicine, Division of Gastroenterology/Hepatology, Indiana University School of Medicine, Indianapolis, and lead investigator of the study. "Building on these results, the boceprevir Phase III clinical program individualizes treatment based on response, utilizing RVR criteria at week 4 of boceprevir treatment to determine overall duration of therapy. Based on the RVR rate seen in this Phase II study, we are hopeful that the majority of patients can be treated with 28 weeks of therapy."

Part II of the HCV SPRINT-1 study explored a low-dose ribavirin strategy in which boceprevir was given in combination with PEGINTRON and low-dose REBETOL for 48 weeks. SVR for the low-dose REBETOL arm was 36 percent (n=21/59) compared to 50 percent for a 48-week control arm with PEGINTRON and standard-dose REBETOL plus boceprevir (n=8/16). In contrast to the results seen in Part I, the low-dose REBETOL regimen was associated with increased viral breakthrough during treatment, higher relapse rates after the end of treatment and lower SVR, strongly indicating that standard-dose ribavirin is required to optimize response.

Another key finding of the HCV SPRINT-1 study is that treatment-emergent anemia appeared to be associated with higher SVR, with anemic patients (hemoglobin decreasing to less than 10 g/dL) having higher SVR rates than those wi
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
2. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
3. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
4. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
5. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
6. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
7. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
8. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
9. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
10. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
11. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Del., Dec. 15 The U.S. Food and ... (EMDAC) today voted 12 yes, 4 no, and 1 ... the observed risks to support the use of CRESTOR® ... Men greater than or equal to 50 years, ... Fasting LDL < 130 mg/dL; hsCRP greater than ...
(Date:12/15/2009)... 15 SRI International, an independent nonprofit ... of U.S. patent 7,592,021 for a new bioadhesive ... drugs through the human body,s mucous membranes. This ... allows for a much longer release time compared ... Transmucosal delivery is an effective means to introduce ...
(Date:12/15/2009)... something looks like up close and personal? ASPEX wants ... Microscope (PSEM), kicked off its "Send Us Your Sample" ... scanned by one of their PSEMs. ,, ... 5mm and an imaging resolution of 25nm, capable of ... will not only scan your sample, but will post ...
Breaking Medicine Technology:Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 2Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 3Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 4Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 5SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 1Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 2Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 3 26amp 3B 238220 3BI Can See Like a Hawk 21 26amp 3B 238221 3B Says Inside MMA Host Bas Rutten 61587 1 26amp 3B 238220 3BI Can See Like a Hawk 21 26amp 3B 238221 3B Says Inside MMA Host Bas Rutten 61587 22009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa 28TM 29 Brand Name 6361 12009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa 28TM 29 Brand Name 6361 22009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa 28TM 29 Brand Name 6361 32009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa 28TM 29 Brand Name 6361 42009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa 28TM 29 Brand Name 6361 5
... NEW YORK, Nov. 5 Immtech Pharmaceuticals,Inc. (Amex: ... received $5.1 million from a,scientific consortium led by ... which received funds from The Bill & Melinda ... fighting African sleeping,sickness (trypanosomiasis) and leishmania. This grant ...
... from the,Alzheimer,s Foundation of America (AFA) today called ... light of research,indicating that cases of mild and ... early diagnosis can lead to appropriate treatment and,other ... executive officer, and J. Wesson Ashford,M.D., Ph.D., senior ...
Other Medicine Technology:Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 2Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 4
(Date:12/15/2009)... about taxes in the healthcare bill ,, WASHINGTON, ... place under the "Naughty" column on Americans for Tax Reform,s ... telling a brazen lie on the floor of the United ... raise taxes. ,, Speaking on the U.S. Senate floor ... I have also heard it argued that health ...
(Date:12/15/2009)... Incidence fell in area where all couples of reproductive ... 14 (HealthDay News) -- The number of children born ... who might be CF mutation carriers increases, a new ... in an area of northeast Italy for many years. ... progressive decline in the number of infants born with ...
(Date:12/15/2009)... some sobering statistics concerning the parallel rise in diabetes and obesity ... means of combating this trend afflicting their workforce. , ... ... are climbing across America due in large part to the alarming ... Association has stated that the rate of diabetes could be cut ...
(Date:12/15/2009)... Dec. 15 4R Systems, Inc., a ... solutions which help retailers significantly increase profits by ... announced today that The Vitamin Shoppe has been ... "4R,s store and DC inventory solutions have helped ... and in-stocks over the last two years," said ...
(Date:12/15/2009)... CITY, Dec. 15 The new compact LifeSpan ... ( www.LifeSpanFitness.com ), was highly praised by ... treadmills for 2010. The compact TR200 folding treadmill received ... Best Treadmill under $1000. ,, The compact LifeSpan ... in small workout spaces. "This category buster is a ...
Breaking Medicine News(10 mins):Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2
... say, , , MONDAY, March 9 (HealthDay News) -- If you ... not be all in your head. , Harvard researchers ... to visit emergency rooms with migraines if the outside temperature ... it is not as significant. , The findings do not ...
... Public Service Ad Aimed at Young WomenWASHINGTON, March 9 ... Health and Human Services, Office on Women,s Health in observing ... on March 10 by hosting a variety of activities, ... National Women and Girls HIV and AIDS Awareness Day ...
... March 9 Ross R. Moody, President of National Western ... fourth quarter 2008 consolidated net earnings of $10.9 million, or ... net earnings of $29.2 million, or $8.22 per diluted Class ... the year ended December 31, 2008, the Company reported consolidated ...
... 9 Today, Family Research Council President ... decision to abolish limits on federal funding of ... renew the Dickey-Wicker Amendment. (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO )"Sadly, ... door wider to embryonic stem cell research. In ...
... better distinguish cancer types, researcher says, , , MONDAY, March ... accurately determines the stage of bladder cancer could help ... says. , U.S. researchers studied 70 bladder cancer specimens ... accurate in identifying bladder cancer that can be treated ...
... Borrowing from the iconic I Love NY logo, Ogilvy ... in a new campaign logo for the American Red Cross ... designed to recruit New Yorkers to become Red Cross Reserve ... of Governor David Paterson -- is part of a multi-channel ...
Other Medicine News:Health News:Warmer-Than-Average Temperatures Raise Migraine Risk 2Health News:Warmer-Than-Average Temperatures Raise Migraine Risk 3Health News:YWCAs to Observe National Women and Girls HIV and AIDS Awareness Day on March 10th 2Health News:National Western Life Announces 2008 Fourth Quarter and 2008 Earnings 2Health News:National Western Life Announces 2008 Fourth Quarter and 2008 Earnings 3Health News:National Western Life Announces 2008 Fourth Quarter and 2008 Earnings 4Health News:Technique Might Prevent Some Bladder Removals 2Health News:American Red Cross of Greater New York Launches New Effort to Recruit 10,000 Disaster Volunteers 2Health News:American Red Cross of Greater New York Launches New Effort to Recruit 10,000 Disaster Volunteers 3
Insert only, Ethicon, small clip size...
Medium clip size, 10mm...
Ethicon, medium-large clip size, 10mm, rotatable take apart...
... appliers in 10mm and 5mm sizes. Our ... clip placement., ,The LIGACLIP ERCA Endoscopic ... single patient use instrument designed to provide ... Trocars. The instrument delivers 20 titanium clips ...
Medicine Products: